Aegle BioTech

Coral Springs, United States
Develops innovative technologies for cancer vaccines and therapeutics.

About Aegle BioTech

Aegle BioTech was a Healthcare company based in Coral Springs (United States). It develops innovative technologies for cancer vaccines and therapeutics. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Pharmaceuticals and Cancer Treatments. Its legal entity in India is Aegle Biotech Private Limited (U24239TG2005PTC047807). Similar companies include TScan Therapeutics, GigaGen and Shattuck Labs; 3 of its 3 listed similar companies have raised funding.

Company details

Aegle BioTech develops innovative technologies for cancer vaccines and therapeutics through providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and cancer treatments. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Board of directors of Aegle Biotech Private Limited (Aegle BioTech)

Aegle Biotech Private Limited is the primary company behind Aegle BioTech. The board of Aegle Biotech Private Limited currently have 2 directors; the longest-serving is Kandikatla Praveen Kumar, appointed in 2005.

DirectorDesignationAppointedTenureEntity
Kandikatla Praveen Kumar
DIN 01854803
Director18 Oct 200521 yrsAegle Biotech Private Limited
Akula Sai Sreedhar Rao
DIN 01854768
Director18 Oct 200521 yrsAegle Biotech Private Limited

Similar companies to Aegle BioTech

Aegle BioTech has 3 listed similar companies in our database, 3 of them funded. They include TScan Therapeutics, GigaGen and Shattuck Labs.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
tscan.com1995Boston, United States$158.3M154
T cell-based treatments for immunological and oncological disorders are developed.
gigagen.com2011San Francisco, United States$36.13M36
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
shattucklabs.com2016Austin, United States$165.4M89
An immunotherapy platform for oncology and other diseases is developed.
Premium access

Detailed similar companies of Aegle BioTech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Immunology & Cancer Therapeutics

3 companies that operate in the same segment as Aegle BioTech (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Targeted and immune-oncology drugs for cancer treatment are developed.
2010Cambridge, Massachusetts, United StatesUSD 172 M
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aegle BioTech

Aegle BioTech is headquartered in Coral Springs, United States. It is registered at Coral Springs, Florida, United States.

Aegle BioTech develops innovative technologies for cancer vaccines and therapeutics through providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and cancer treatments. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Aegle BioTech's top competitors include GigaGen, Shattuck Labs and TScan Therapeutics.

Aegle BioTech operates through Aegle Biotech Private Limited.

The legal entities of Aegle BioTech currently have 2 directors, including Kandikatla Praveen Kumar, Akula Sai Sreedhar Rao.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available